Eriko Tokunaga

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Eriko Tokunaga

May 15, 2025, 07:00 | Insight

Paolo Tarantino: The most discussed side effect of T-DXd is ILD

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post by Naoto T Ueno, Director…

May 13, 2025, 10:59 | Science

Naoto T Ueno: The Impact of Enhertu on Quality of Life

Naoto T Ueno, Director of the University of Hawaii Cancer Center, shared an article on X:…

Apr 9, 2025, 08:51 | Drugs

Elvina Almuradova: Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Elvina Almuradova, Ambassador at European School of Oncology, shared an article Komal Jhaveri and her…

Dec 12, 2024, 16:50 | Insight

Imlunestrant and Abemaciclib: A Study in Advanced Breast Cancer

Imlunestrant has been approved for the treatment of breast cancer. It is a next-generation, brain-penetrant,…

Dec 12, 2024, 13:36 | Blog

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Erika Hamilton, The Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on…

All: 5 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023